VRTX VERTEX PHARMACEUTICALS INC

Ownership history in MANNING & NAPIER ADVISORS LLC  ·  13 quarters on record

AI Ownership Summary

MANNING & NAPIER ADVISORS LLC reported VERTEX PHARMACEUTICALS INC (VRTX) in 13 quarterly 13F filings from 2024 Q2 through 2025 Q4. Peak portfolio weight reached 2.52% in 2025 Q4. The latest visible filing shows VRTX at 2.52% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this VRTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was MANNING & NAPIER ADVISORS LLC's position in VERTEX PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

VRTX was reported at 2.52% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
2.52% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How MANNING & NAPIER ADVISORS LLC held VRTX — position size vs. price
% of Fund (quarterly)    VRTX price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 427,603 -47,219 -9.9% 2.52% $194.0M 2026-02-14 (Est.) $491.47
2025 Q3 ADDED 474,822 +241,242 +103.3% 2.39% $187.7M 2025-10-27 $420.17
2025 Q2 REDUCED 233,580 -1,528 -0.6% 1.24% $104.0M 2025-08-13 $395.92
2025 Q1 ADDED 235,108 +84,982 +56.6% 1.41% $114.0M 2025-04-22 $490.47
2024 Q4 REDUCED 150,126 -5,635 -3.6% 0.69% $60.5M 2025-01-23 $439.73
2024 Q3 REDUCED 155,761 -2,571 -1.6% 0.80% $72.4M 2024-10-17 $498.73
2024 Q2 REDUCED 158,332 -727,536 -82.1% 0.84% $74.2M 2024-07-11 $492.13
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About MANNING & NAPIER ADVISORS LLC and VRTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has MANNING & NAPIER ADVISORS LLC reported owning VRTX?

MANNING & NAPIER ADVISORS LLC reported VRTX across 7 quarterly 13F filings, from 2024 Q2 through 2025 Q4.

What was the largest reported VRTX position in MANNING & NAPIER ADVISORS LLC's portfolio?

The largest reported portfolio weight for VRTX was 2.52% in 2025 Q4.

What is the latest reported VRTX position on this page?

The most recent filing on this page is 2025 Q4, when MANNING & NAPIER ADVISORS LLC reported 427,603 shares, equal to 2.52% of portfolio, with an estimated market value of $194.0M.

What does the chart on this VRTX ownership page compare?

The chart compares MANNING & NAPIER ADVISORS LLC's quarterly VRTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to MANNING & NAPIER ADVISORS LLC Holdings